title: Seropositive arthritis in chronic lymphocytic leukemia: a remark on B cell-mediated autoimmunity.
authors.forename: Ibrahim Koral
authors.initials: IK
authors.lastname: Onal
authors.forename: Levent
authors.initials: L
authors.lastname: Ozçakar
authors.forename: Omer
authors.initials: O
authors.lastname: Dizdar
authors.forename: Yahya
authors.initials: Y
authors.lastname: Büyükaşik
authors.forename: Semra
authors.initials: S
authors.lastname: Dündar
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology*; D015551:Autoimmunity / Q000276:immunology*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology*; D008297:Male; D018570:Risk Assessment; D012720:Severity of Illness Index
chemical_list: D018501:Antirheumatic Agents